Skip to content

Dianthus Therapeutics

US · DNTH #2155 by market cap Listed 1970
84.55 -0.28 -0.33%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:59

About Dianthus Therapeutics

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.

Founded
2015
CEO
Mr. Marino Garcia
Employees
92
Headquarters
New York, New York, United States of America
Fiscal year end
12-31
Website
dianthustx.com

Company profile

Exchange
US
Symbol
DNTH
Market-cap rank
#2155
Listing date
1970-01-01
Market cap
4.76B
Float cap
4.75B
Shares out
56.31M
Float shares
56.23M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:59:44 · For reference only, not investment advice and not tailored to your situation.

Dianthus Therapeutics discussion 0 comments

Add a comment